The first clinical experience with a novel “locking” microcatheter in chronic coronary total occlusions
EuroIntervention 2017;12:e1883-e1888 published online November 2016 published online e-edition February 2017. DOI: 10.4244/EIJ-D-16-00272
Simon J. Wilson1*, MD; Joren Maeremans2, MSc; Simon J. Walsh3, MD; Colm G. Hanratty3, MD; Markus Meyer-Gessner4, MD; Jo Dens5, MD, PhD; Evald H. Christiansen6, MD; Alexander Bufe7, MD; James C. Spratt8, MD
1. Royal Infirmary of Edinburgh, Edinburgh, Scotland, United Kingdom; 2. Universiteit Hasselt, Hasselt, Belgium; 3. Belfast City Hospital, Belfast, Northern Ireland, United Kingdom; 4. Augusta Krankenhaus, Duesseldorf, Germany; 5. Ziekenhuis Oost-Limburg,
Aims: A novel “locking” microcatheter has been developed to address residual failure modes in chronic total occlusion (CTO) percutaneous coronary intervention (PCI). The aim of this study
